<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03574831</url>
  </required_header>
  <id_info>
    <org_study_id>xhnk001</org_study_id>
    <nct_id>NCT03574831</nct_id>
  </id_info>
  <brief_title>the Efficency and Safety of Stretta in GERD</brief_title>
  <official_title>the Efficency and Safety of the Endoscopic Radiofrequency Procedure in Gastroesophageal Reflux Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Capital Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Capital Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluated the efficency and safety of the endoscopic radiofrequency
      procedure(Stretta) in adult gastroesophageal patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Gastro-esophageal reflux disease (GERD) is the most common outpatient diagnosis in
      gastroenterology and is associated with a significant burden on the healthcare system. Proton
      pump inhibitors (PPIs) are the mainstay of GERD treatment,howerver, some patients have an
      unsatisfactory response to high doses of PPIs, which remains a challenge. The Stretta
      procedure, a radiofrequency (RF) application to the lower esophageal sphincter (LES), was
      introduced about 15 years ago as an alternative to chronic medical therapy or surgical
      intervention for GERD.The Stretta procedure appears to result in thickening of the LES,
      decreased transient LES relaxation rate and reduced esophageal acid exposure.The majority
      studies of Stretta were held in USA and Europe, the sduty of Stretta in Asia is rare. The
      investigators propose to perform a prospectively observiton study to evaluate the efficency
      of the Stretta procedure in patients of refractory GERD in China.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2, 2016</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>GERD-HRQL scores</measure>
    <time_frame>[Time Frame: Change from Baseline HRQL scores at 1 month;Change from Baseline HRQL scores at 2 months;Change from Baseline HRQL scores at 6 months;Change from Baseline HRQL scores at 1 year]</time_frame>
    <description>the improvement of GERD-HRQL scores after procedure.Scale ranges 0-50 points, the lower score means the better efficacy.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of patients who report independence from Proton Pump Inhibitor (PPI) drug post Stretta procedure</measure>
    <time_frame>Change from Baseline number at 1 month;Change from Baseline number at 2 months;Change from Baseline number at 6 months;Change from Baseline number at 1 year]</time_frame>
    <description>Questionnaire will be provided to each participant to report no further requirement of PPI drug post procedure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Demeester Score</measure>
    <time_frame>1 year</time_frame>
    <description>the change of Demeester scores after procedure. The lower, the better.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LES Pressure</measure>
    <time_frame>1 year</time_frame>
    <description>the change of LES pressure after procedure.The higher, the better.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with treatment-related adverse events</measure>
    <time_frame>1 month</time_frame>
    <description>Number of participants with treatment-related adverse events</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>GERD</condition>
  <condition>Radiofrequency Ablation</condition>
  <arm_group>
    <arm_group_label>Stretta</arm_group_label>
    <description>Radio Frequency Ablation (RFA) using a Stretta device.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Stretta</intervention_name>
    <description>Stretta</description>
    <arm_group_label>Stretta</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with refractory GERD symptoms, without major esophagus motility disorder and large
        hiatus hernia.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age &gt; 18 years

          2. Small hiatus hernia (&lt; 2-3 cm)

          3. Los Angeles Grade 'A' or 'B' Reflux Esophagitis or non erosive esophagitis

          4. LES pressure ï¼œ15 mm Hg

          5. PPI dependent / refractory GERD

          6. abnormal 24h esophagus pH-impedance monitoring

        Exclusion Criteria:

          1. Age &lt; 18 years

          2. Large hiatus hernia (&gt; 3 cm)

          3. Los Angeles Grade 'C' or 'D' Reflux Esophagitis

          4. LES pressure &gt; 15 mm Hg

          5. Underlying coagulation disorder

          6. Previous Esophageal or Gastric surgery

          7. Pregnant

          8. major esophagus motility disorder according to Chicago v3.0
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chuan Zhang, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Gatroenterology department,Beijing Tong Ren Hospital, Capital Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hao Zi Guo, MD</last_name>
    <phone>86+15801227696</phone>
    <email>zihaoguo@139.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Gastroenterology department,Beijing Tong Ren Hospital, Capital Medical University.</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hao Zi Guo, MD</last_name>
      <phone>86+15801227696</phone>
      <email>zihaoguo@139.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>June 21, 2018</study_first_submitted>
  <study_first_submitted_qc>June 29, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 2, 2018</study_first_posted>
  <last_update_submitted>July 11, 2018</last_update_submitted>
  <last_update_submitted_qc>July 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Capital Medical University</investigator_affiliation>
    <investigator_full_name>Guo Zihao</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>GERD</keyword>
  <keyword>Radiofrequency ablation</keyword>
  <keyword>efficiency</keyword>
  <keyword>safety</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

